The prophylactic effects of goshajinkigan on TC therapy-induced peripheral neuropathy
Phase 2
- Conditions
- Ovarian cancer
- Registration Number
- JPRN-UMIN000021361
- Lead Sponsor
- Tohoku Gynecologic Oncology Unit
- Brief Summary
in analyzing the final data
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients who had received goshajinkigan. 2) The patients with severe peripheral neuropathy. 3) The patients with diabetic neuropathy, 4) The pregnant or breast feeding women. 5) The patients whom the doctor recognizes unsuitable subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method